Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Silk Coat for Diamonds Makes Sleek New Imaging and Drug Delivery Tool

Published: Tuesday, January 28, 2014
Last Updated: Tuesday, January 28, 2014
Bookmark and Share
New kind of tiny glowing particle could provide a novel technique for biological imaging and drug delivery.

The new particles, just tens of nanometers across, are made of diamond and covered in silk. They can be injected into living cells, and because they glow when illuminated with certain kinds of light, biologists can use them to peer inside cells and untangle the molecular circuitry that governs cellular behavior, or to study how cells react to a new drug. The silk-coated diamond particles could also potentially be used someday in the clinic, by allowing doctors to send infection-fighting antibiotics to a targeted area of the body.

A team of researchers from Australia and the United States describes this new hybrid diamond-silk material in a paper published today in The Optical Society’s (OSA) journal Biomedical Optics Express.

Nanodiamonds similar to those in this study have been explored previously for their potential medical uses, but this is the first time silk has been incorporated with nanodiamonds, said Asma Khalid of the University of Melbourne, who is the first author of the Biomedical Optics Express paper. "This nanodiamond-silk hybrid material is important due to the potential it offers to the fields of bioimaging, biosensing and drug delivery," she explained.

Diamonds are crystals of carbon. But they can be made with defects—other atoms inserted in the crystal structure—and these defects allow them to do tricks that flawless diamonds can’t, such as absorbing and reemitting light of certain wavelengths, a process called fluorescence. Because these fluorescent nanodiamonds are bright, stable, and harmless to living tissue – and can work at room temperature – researchers have been exploring their use in biological imaging and sensing. But the edges around the particles tend to be rough and may cause  the nanodiamonds to become trapped inside cell membranes.

Previously, other researchers have addressed this problem by coating the particles with lipids, a class of molecules found in fats and waxes. According to the new study, however, a better solution is to cover the nanodiamonds in silk, which is transparent, flexible, compatible with biological tissue, and biodegradable, so it won't leave any harmful byproducts inside the body.

When the researchers tested their new hybrid material, they found that the silk remains transparent, meaning that it does not block the glow of the nanodiamonds. They also discovered that the silk not only preserves the optical properties of the nanodiamonds, but it enhances their brightness by two to four times. Finally, the new material appears to be safe for use in the body: it left no damaging effects even after spending two weeks implanted inside living tissue, suggesting that it is nontoxic and non-inflammatory, the researchers say.

In the future, the team envisions a range of nanodiamond-silk structures that could help researchers improve techniques for fighting infections in targeted areas of the body. A thin film of the new substance, carrying drugs, could be implanted directly into an infected area, minimizing the patient’s exposure to the drugs. Silk can also be designed to degrade at a certain rate, which would allow clinicians to control the release of medications.

In addition to the University of Melbourne, the researchers are affiliated with the University of Sydney and the Silk Lab at Tufts University in Massachusetts.

Paper: “Synthesis and Characterization of Biocompatible Nanodiamond-Silk Hybrid Material,” Khalid, A. et al., Biomedical Optics Express, Vol. 5, Issue 2, pp. 596-608 (2014).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rapidly Killing Bacteria
Light-activated gold nanoparticles destroy potentially deadly bacterial cells in seconds.
Monday, March 21, 2016
Scientific News
Rates of Nonmedical Prescription Opioid Use Disorder Double in 10 Years
Researchers at NIH have found that the nonmedical use of prescription opioids has more than doubled among adults in the United States from 2001-2002 to 2012-2013.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
‘Human-on-a-Chip’ Could Replace Animal Testing
Researchers are developing a “human-on-a-chip,” a miniature external replication of the human body, integrating biology and engineering with a combination of microfluidics and multi-electrode arrays.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
‘Missing Tooth’ Hydrogels Handle Hard-to-Deliver Drugs
Rice University’s custom hydrogel traps water-avoiding molecules for slow delivery.
Copper is Key in Burning Fat
Berkeley Lab scientist says results could provide new target for obesity research.
Better Animal Model to Improve HIV Vaccine Development
Penn study identifies a new tool to produce better HIV vaccine designs.
Identifying Side-Effects At Early Stages Of Drug Development
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK).
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!